5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.1 KiB
5.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Drugs, Prescription - As enacted, authorizes a healthcare provider licensed as a nurse or physician assistant to prescribe a buprenorphine product as approved by the FDA for use in recovery or medication-assisted treatment if certain criteria are met. - Amends TCA Title 33; Title 53; Title 63 and Title 68. | Drugs, Prescription - As enacted, authorizes a healthcare provider licensed as a nurse or physician assistant to prescribe a buprenorphine product as approved by the FDA for use in recovery or medication-assisted treatment if certain criteria are met. - Amends TCA Title 33; Title 53; Title 63 and Title 68. | us/states/tn | Tennessee General Assembly | 113 | HB 2093 | Tennessee HB 2093 (113) |
|
|
enacted |
|
3 | 31 | 5 | 2024-01-24 | 2024-05-28 | openstates | ocd-bill/c8422cae-33af-459f-b166-1d79e7fcd63a | http://wapp.capitol.tn.gov/apps/BillInfo/default.aspx?BillNumber=HB2093&GA=113 | 333b101f7752d12bd3675269f35927e6e2ed7124a3b58e46d2a981b1129e10e1 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Tennessee HB 2093 (113) — Drugs, Prescription - As enacted, authorizes a healthcare provider licensed as a nurse or physician assistant to prescribe a buprenorphine product as approved by the FDA for use in recovery or medication-assisted treatment if certain criteria are met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Amendment HA0953 (committee substitute) — source
- Amendment SA0985 (committee substitute) — source
- Current Version (committee substitute) — source
Votes
- HOUSE HEALTH COMMITTEE: Rec. for pass. if am., ref. to Calendar & Rules Committee 4/3/2024 (3) — 0–0 (pass) · lower
- FLOOR VOTE: Third Consideration 4/22/2024 Passed (1) — 25–2 (pass) · upper
- HOUSE HEALTH SUBCOMMITTEE: Rec for pass if am by s/c ref. to Health Committee 3/26/2024 (4) — 0–0 (fail) · lower
- FLOOR VOTE: REGULAR CALENDAR AS AMENDED PASSAGE ON THIRD CONSIDERATION 4/16/2024 Passed (1) — 89–2 (pass) · lower
- HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Regular Calendar for 4/16/2024 4/11/2024 (2) — 0–0 (fail) · lower
Sponsors
- Vaughan — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-01-24 Filed for introduction
filing - 2024-01-25 Intro., P1C.
introduction - 2024-01-29 P2C, caption bill, held on desk - pending amdt.
- 2024-03-06 Placed on s/c cal Health Subcommittee for 3/12/2024
- 2024-03-06 Assigned to s/c Health Subcommittee
referral-committee - 2024-03-06 Ref. to Health Committee
referral-committee - 2024-03-12 Action Def. in s/c Health Subcommittee to 3/19/2024
- 2024-03-13 Placed on s/c cal Health Subcommittee for 3/19/2024
- 2024-03-19 Sponsor(s) Added.
sponsorship - 2024-03-20 Placed on s/c cal Health Subcommittee for 3/26/2024
- 2024-03-20 Action Def. in s/c Health Subcommittee to 3/26/2024
- 2024-03-26 Rec for pass if am by s/c ref. to Health Committee
referral-committee - 2024-03-27 Placed on cal. Health Committee for 4/3/2024
- 2024-04-03 Rec. for pass. if am., ref. to Calendar & Rules Committee
committee-passage-favorable - 2024-04-10 Placed on cal. Calendar & Rules Committee for 4/11/2024
- 2024-04-11 H. Placed on Regular Calendar for 4/16/2024
- 2024-04-16 Engrossed; ready for transmission to Sen.
receipt - 2024-04-16 Passed H., as am., Ayes 89, Nays 2, PNV 2
passage - 2024-04-16 Sponsor(s) Added.
sponsorship - 2024-04-16 H. adopted am. (Amendment 1 - HA0953)
amendment-passage - 2024-04-17 Received from House, Passed on First Consideration
introduction - 2024-04-22 Passed Senate, Ayes 25, Nays 2
passage - 2024-04-22 Amendment withdrawn. (Amendment 1 - SA0985)
- 2024-04-22 Senate substituted House Bill for companion Senate Bill.
substitution - 2024-04-24 Enrolled; ready for sig. of H. Speaker.
enrolled - 2024-05-01 Signed by H. Speaker
passage - 2024-05-09 Signed by Senate Speaker
passage - 2024-05-10 Transmitted to Governor for his action.
executive-receipt - 2024-05-21 Signed by Governor.
executive-signature - 2024-05-28 Effective date(s) 05/21/2024
- 2024-05-28 Pub. Ch. 980
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/c8422cae-33af-459f-b166-1d79e7fcd63a. Confidence: reported (aggregated from official Tennessee legislature records).